Send To friend

Please type in Friend Name
Please enter only Characters
Please type in Friend Email
Please enter a valid EmailID
Please type in Your Name
Please enter only Characters
Please type in Your Email
Please enter a valid EmailID

Thank You

Thank you for submitting your feedback. We shall revert to you shortly.

> Nuclear Medicine
  • PET-CT imaging in Oncology.
  • PET-CT imaging guided applications in specific oncology areas.
  • Radiation therapy planning : PET-CT guided
  • Sentinel node imaging in breast cancer and radioguided surgery
  • Parathyroid imaging
  • PET-CT in Neurology and Nuclear Neurology, Epilepsy.
  • PET-CT in Aortoarteritis / Takayasu arteritis, Infections
  • Nuclear Cardiology and FDG PET for Myocardial Viability
  • PET-CT imaging in infective endocarditis, intracardiac device infections, cardiac - inflammation.
  • Radioactive iodine therapy (I-131 therapy) for hyperthyroidism
  • Radioembolisation therapy : SIRT / Theraspheres for hepatocellular cancer and liver - metastasis from colorectal cancer
  • Radiosynovectomy
  • Bone pain palliation therapy
  • Lu-177 PSMA therapy for prostate cancer.
  • Lu-177 DOTA therapy for neuroendocrine tumors
  • Nuclear Nephrology.

Dr. Natasha Singh is Senior Consultant and Head of department of Nuclear Medicine and PET-CT at P D Hinduja National Hospital & Medical Research Centre, Mumbai, India, with over 16 years of experience, and is a qualified Post Graduate Nuclear Medicine Teacher.

She has gained extensive experience in the speciality of Nuclear Medicine & PET-CT, with expertise across wide spectrum including PET-CT imaging, PET-CT guided applications, Diagnostic Radionuclide imaging in Oncology and Benign conditions, PET-CT in infections and inflammation, PET-MRI and SPECT-MRI modalities in pediatric epilepsy, Parathyroid imaging including SPECT-CT, Therapeutic radionuclide applications including thyroid disorders, prostate cancer, neuroendocrine tumors, bone pain palliation, radioembolisation procedures for hepatocellular cancer and liver metastasis, radiosynovectomy.

She specializes in Diagnostic Molecular PET-CT imaging, with extensive work since 2003 in various cancers including Non Hodgkins lymphoma, Hodgkins lymphoma, breast cancer, lung cancer, bone and soft tissue cancers, cartilaginous tumors, cancers of head and neck, cancers of gastrointestinal tract, and cancers of genitourinary system, amongst others. Her expertise extends to PET-CT guided Radiation Therapy Planning in certain cancers. She also specializes in PET-CT imaging in benign conditions for infections and inflammation, specifically Aortoarteritis / Takayasu disease, and fever of unknown origin.

She started the pre-therapy diagnostic somatostatin receptor scan imaging with isotope Lutetium under the able guidance of a renowned nuclear medicine specialist, which was subsequently studied at various nuclear medicine centres across India. After training in the radiolabelled peptide receptor therapy for Neuroendocrine cancer at “Royal Liverpool University Hospital”, Liverpool, UK, in 2009, she was instrumental in setting up this cancer therapy in the private sector as part of P D Hinduja National Hospital activity.

Her expertise includes Nuclear Cardiology including FDG PET imaging for myocardial viability, FDG PET in cardiac inflammations & infective endocarditis & intracardiac device infections, Nuclear Neurology with special attention towards Epilepsy, Nuclear Nephrology, and various other general Nuclear Medicine Procedures.      

Dr. Natasha Singh is a qualified post graduate Nuclear Medicine Teacher as per the Eligibility Qualifications criteria of Teachers, in accordance with the National Board of Examinations India for medical graduates undergoing training for post graduate specialization (DNB) in Nuclear Medicine. She is part of the faculty conducting Post Graduate training programme for Medical Graduates in the speciality of Nuclear Medicine & PET-CT recognized by the National Board. She has trained several Medical Doctors enrolled in the ‘post graduate DNB – Nuclear Medicine & PET-CT degree course’ at P D Hinduja National Hospital & Medical Research centre, Mumbai, India.
She has been honoured as the distinguished National Board of Examinations teacher in Nuclear Medicine, and awarded the ‘Teacher’s Award’ by Association of National Board Accredited Institutions Maharashtra, Gujarat, Goa Region -2019
She has also conducted training of nurses, technologists, and paramedical personnel.

Dr. Natasha Singh completed her Post Graduate Degree in the speciality of Nuclear Medicine, Diplomate of National Board, New Delhi, in 2005. She underwent her training at P D Hinduja National Hospital & Medical research centre, Mumbai, a premier multi-speciality hospital accredited for Post Graduate Medical Courses (DNB) under National Board of Examinations.

She qualified the Radiation Safety Officer Examination in 2006, conducted by Atomic Energy Regulatory Board (AERB), Bhaba Atomic research Centre (BARC), Mumbai, India.

She gained experience as senior registrar in Bio-Imaging PET-CT and SPECT-CT unit at Tata Memorial Hospital, Mumbai, India, 2006 – 2007. She underwent extensive training specialized towards PET-CT imaging and systems.

She trained at Royal Liverpool University Hospital, Liverpool, UK, in 2009, with specialized training towards Radiolabelled Peptide Receptor Therapy for Neuroendocrine cancer.

She also trained in various aspects of radionuclide therapy special focus on Lu-177 PSMA for prostate cancer and Lu-177 Dotatate/Dotatoc for neuroendocrine tumor, and Ga68 PSMA PET-CT diagnostic imaging - at ‘University Klinikum Hospital’, Ulm, Germany in 2018.

She participated and trained with multidisciplinary team meetings including clinical-scan sessions in nephrourology, neuroblastoma, pediatric epilepsy, musculoskeletal conditions, endocrinology - at ‘Great Ormond Street Hospital for children’, London in 2018.

She trained in nuclear cardiology, protocols and quality control aspects of SPECT-CT & PET-CT, observer in Digital PET-CT imaging, CT dose reduction protocols involved during PET imaging - at ‘Emory University school of medicine’, Atlanta, USA in 2018.

She was an active participant in “The 5th international workshop on PET in lymphoma” 2014, Menton, France - where the workshop brought together haematologists and nuclear medicine physicians in discussion for advances in the field of lymphoma imaging and to set new international trials.

She was instrumental in formation of Indo-European Education Forum and conducted two Indo-European Nuclear Medicine post graduate training courses in 2010 and 2011:with participation of experienced teachers from Europe. Amongst other programmes, she also conducted An All India Post Graduate teaching programme for DNB (Nuclear Medicine & PET-CT) students from all post graduate institutes and DNB centres from India, at New Delhi,2008 : with participation of international faculty from USA, UK, Australia.

Dr. Natasha Singh completed her M.B.B.S from Government Medical College, Patiala, India in 1996. She trained in various fields of medicine for an overview of diseases and disorders, and hands on insight towards various treatments and management protocols for better vision and understanding of treating the patient, with better understanding and utility of the field of diagnostics specially Imaging. Amongst other trainings, she gained experience as Registrar & Incharge treadmill stress testing lab :1997–1999, at ‘Heart Institute & Research centre’, Chandigarh, India. She received training in clinical and non invasive cardiology including ECG treadmill stress test, Exercise and pharmacological stress echo, Colour doppler echocardiography. She also worked as Registrar and trained in the department of Chest Medicine & TB at ‘Government Medical College Chandigarh’ in 1998. She also trained and worked as Registrar in the department of Gynaecology at ‘ESI hospital’, New Delhi from 2000-2001.

Room NoMondayTuesdayWednesdayThursdayFridaySaturday
21F 15:00-16:0015:00-16:4015:00-16:40--

F - Free OPD